Skip to content

13F-HR filed by Rhenman & Partners Asset Management AB

Rhenman & Partners Asset Management AB filed this 13F-HR for the quarter ended 2018-09-30, filed 2018-10-03, with 88 holding rows worth $997,986,000.

Accession
0001415889-18-001462
Filed
2018-10-03
Accepted by EDGAR
acceptance time not in the bulk data set
Ingested
Source
SEC quarterly data set

Original filing

13F report for Q3 2018

A holdings report, 88 entries on the cover page, a total value of $997,986,000 stated on the cover page (in dollars after the unit check, H1), rows summing to $997,986,000 with VALUE read as thousands by filing date, 13F file number 028-15944. The quarter's positions are built on this report. The resolved quarter.

The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).

Issuer as filedCUSIPClassAmountValueValue read asType
CIGNA CORPORATION125509109COM174,691$36,379,000thousands by filing date
CVS Health Corporation126650100COM438,868$34,548,000thousands by filing date
ALEXION PHARMACEUTICALS INC015351109COM243,329$33,825,000thousands by filing date
Vertex Pharmaceuticals Incorporated92532F100COM142,465$27,459,000thousands by filing date
INCYTE CORP COM45337C102Stock376,916$26,037,000thousands by filing date
BIOMARIN PHARMACEUTICAL INC09061G101COM264,849$25,682,000thousands by filing date
ABIOMED INC003654100COM55,701$25,052,000thousands by filing date
Medtronic PlcG5960L103COM249,874$24,580,000thousands by filing date
UnitedHealth Group Inc91324P102COM91,000$24,210,000thousands by filing date
DIPLOMAT PHARMACY INC25456K101COM1,174,411$22,795,000thousands by filing date
EXELIXIS INC COM30161Q104Stock1,261,414$22,352,000thousands by filing date
JAZZ PHARMACEUTICALS PLC SHS USDG50871105Stock126,322$21,239,000thousands by filing date
NOVOCURE LTDG6674U108ORD SHS400,000$20,960,000thousands by filing date
BECTON DICKINSON & CO075887109COM80,000$20,880,000thousands by filing date
Bristol-Myers Squibb Company110122108COM330,000$20,486,000thousands by filing date
SANGAMO THERAPEUTICS INC800677106COM1,197,357$20,295,000thousands by filing date
Abbott Laboratories002824100COM264,552$19,408,000thousands by filing date
Elevance Health, Inc.036752103COM70,000$19,184,000thousands by filing date
NEKTAR THERAPEUTICS640268108COM305,393$18,617,000thousands by filing date
GLAUKOS CORP COM377322102Stock281,279$18,255,000thousands by filing date
Eli Lilly and Company532457108COM170,000$18,243,000thousands by filing date
HORIZON PHARMA PLCG4617B105SHS917,051$17,956,000thousands by filing date
HUMANA INC COM444859102Stock53,000$17,942,000thousands by filing date
SAGE THERAPEUTICS INC78667J108COM124,739$17,619,000thousands by filing date
ARENA PHARMACEUTICALS INC040047607COM NEW366,387$16,861,000thousands by filing date
EDWARDS LIFESCIENCES CORP COM28176E108Stock96,585$16,815,000thousands by filing date
CELGENE CORP151020104COM180,698$16,171,000thousands by filing date
ESPERION THERAPEUTICS INC NEW COM29664W105Stock353,961$15,705,000thousands by filing date
FIBROGEN INC31572Q808COM251,190$15,260,000thousands by filing date
ALNYLAM PHARMACEUTICALS INC COM02043Q107Stock171,950$15,049,000thousands by filing date
Gilead Sciences,Inc.375558103COM189,647$14,643,000thousands by filing date
IOVANCE BIOTHERAPEUTICS INC462260100COM1,290,495$14,518,000thousands by filing date
INTRA-CELLULAR THERAPIES INC46116X101COMMON STOCK654,982$14,213,000thousands by filing date
SEATTLE GENETICS INC812578102COM180,000$13,882,000thousands by filing date
ALLERGAN PLCG0177J108SHS70,045$13,342,000thousands by filing date
Boston Scientific Corporation101137107COM337,968$13,012,000thousands by filing date
ALKERMES PLCG01767105SHS301,610$12,800,000thousands by filing date
AbbVie,Inc.00287Y109COM130,000$12,295,000thousands by filing date
MYOKARDIA INC62857M105COM188,272$12,275,000thousands by filing date
LIVANOVA PLCG5509L101SHS95,000$11,777,000thousands by filing date
ARRAY BIOPHARMA INC COM04269X105Stock768,370$11,679,000thousands by filing date
AGIOS PHARMACEUTICALS INC00847X104COM145,428$11,215,000thousands by filing date
AERIE PHARMACEUTICALS INC00771V108COM180,000$11,079,000thousands by filing date
BIOGEN INC COM09062X103Stock30,000$10,599,000thousands by filing date
WALGREENS BOOTS ALLIANCE INC931427108COM145,000$10,571,000thousands by filing date
AETNA INC NEW00817Y108COM50,000$10,143,000thousands by filing date
NEUROCRINE BIOSCIENCES INC64125C109COM81,677$10,042,000thousands by filing date
FLEXION THERAPEUTICS INC33938J106COM532,812$9,969,000thousands by filing date
CENCORA INC COM03073E105Stock101,520$9,362,000thousands by filing date
IMMUNOMEDICS INC452907108COM425,330$8,860,000thousands by filing date
LOXO ONCOLOGY INC548862101COM50,000$8,542,000thousands by filing date
XENCOR INC98401F105COMMON STOCK209,854$8,178,000thousands by filing date
SPARK THERAPEUTICS INC84652J103COM137,691$7,511,000thousands by filing date
MACROGENICS INC556099109COM341,586$7,324,000thousands by filing date
OMNICELL COM COM68213N109Stock100,375$7,217,000thousands by filing date
REGENERON PHARMACEUTICALS COM75886F107Stock17,000$6,869,000thousands by filing date
RIGEL PHARMACEUTICALS INC766559603COMMON STOCK2,113,988$6,786,000thousands by filing date
PORTOLA PHARMACEUTICALS INC COM737010108Stock242,302$6,453,000thousands by filing date
PEDIATRIX MEDICAL GROUP INC58502B106COM124,674$5,817,000thousands by filing date
CENTENE CORP DEL COM15135B101Stock40,000$5,791,000thousands by filing date
ADAMAS PHARMACEUTICALS INC00548A106COM273,593$5,477,000thousands by filing date
COHERUS ONCOLOGY INC19249H103COM331,131$5,464,000thousands by filing date
REVANCE THERAPEUTICS INC761330109COM203,181$5,049,000thousands by filing date
Viewra, Inc92672L107COM516,623$4,836,000thousands by filing date
MEDICINES CO584688105COM135,000$4,038,000thousands by filing date
ZOGENIX INC.98978L204Common Stock60,000$2,976,000thousands by filing date
ACHILLION PHARMACEUTICALS IN00448Q201COM617,800$2,274,000thousands by filing date
PIERIS PHARMACEUTICALS INC720795103COM300,000$1,680,000thousands by filing date
CHIMERIX INC COM16934W106Stock341,300$1,328,000thousands by filing date
PATTERSON COS INC703395103COM38,500$941,000thousands by filing date
Adverum Biotechnologies, Inc.00773U108Common Stock153,965$931,000thousands by filing date
SUNESIS PHARMACEUTICALS INC867328700COM427,642$855,000thousands by filing date
EXXON MOBIL CORP30231G102COM6,111$520,000thousands by filing date
Qualcomm Incorporated747525103COM6,476$466,000thousands by filing date
Chevron Corporation166764100COM3,733$456,000thousands by filing date
JPMorgan Chase & Co46625H100COM3,726$420,000thousands by filing date
Walt Disney Co254687106COM3,483$407,000thousands by filing date
Pfizer Inc.717081103COM8,754$386,000thousands by filing date
HALLIBURTON CO COM406216101Stock9,221$374,000thousands by filing date
International Business Machines Corporation459200101COM2,461$372,000thousands by filing date
ANHEUSER BUSCH INBEV SA NV SPONSORED ADR03524A108ADR3,788$332,000thousands by filing date
Microsoft Corp594918104COM2,887$330,000thousands by filing date
JANUS HENDERSON GROUP PLC ORD SHSG4474Y214Stock11,828$319,000thousands by filing date
Wells Fargo & Company949746101COM5,858$308,000thousands by filing date
FORD MTR CO COM345370860Stock32,405$300,000thousands by filing date
Alphabet Inc. Reg. Shares A02079K305COM178$215,000thousands by filing date
SYMANTEC CORP871503108COM9,734$207,000thousands by filing date
REGULUS THERAPEUTICS INC75915K101COM492,878$97,000thousands by filing date

Amendment chain

FilingRoleFiledAcceptedIngested
13F-HR 0001415889-18-001462this filing2018-10-03acceptance time not in the bulk data set